Your browser doesn't support javascript.
Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research.
Ison, Michael G; Blumberg, Emily; Halasa, Natasha; Kaul, Dan; Theodoropoulos, Nicole M; Wolfe, Cameron R.
  • Ison MG; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Blumberg E; Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Halasa N; Division of Pediatric Infectious Diseases, Vanderbilt University, Nashville, Tennessee, USA.
  • Kaul D; Division of Infectious Diseases, University of Michigan, Ann Arbor, Michigan, USA.
  • Theodoropoulos NM; Division of Infectious Diseases, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Wolfe CR; Division of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Am J Transplant ; 22(1): 24-27, 2022 01.
Article in English | MEDLINE | ID: covidwho-1412661
ABSTRACT
Despite emerging data suggesting reduced antibody responses among solid organ transplant recipients following SARS-CoV-2 vaccine, critical unanswered questions remain. The clinical implications of the reduced humoral response need to be assessed through prospective studies. Studies are likewise needed to inform which vaccine dosing strategies result in improved immunity and if such approaches maximize protection against severe infection in the vulnerable transplant population.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Ajt.16758

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Ajt.16758